Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.


GREY:IVITF - Post by User

Bullboard Posts
Post by TheActuaryon Aug 03, 2017 8:35am
149 Views
Post# 26541902

Bright future and many catalysts coming

Bright future and many catalysts coming
K2 Fund
K2 Fund is the reason why IMH had access to a lot of capital in the last two PP, but they are also the reason why the stock has a constant selling pressure.
They have now approximately 5.5M shares from a high of 10.4M shares, which were acquired at a price of $1.65 (half warrants at $2.35) and $1.35 (half warrants at $1.75).
Their goal is to sell the stock and keep the half warrants. When the selling pressure will end and the sales license will be granted, the stock will trade over the warrants price and IMH will benefit from another influx of cash.

Sales license
Speaking of sales license, they will get one very soon (AB Labs) and another one sooner than later (Acreage Farms). The 27M warrants available are at a price of 1.65 / 1.75 / 2.35... So no dilution to come without any cash injected at much higher market cap. I won't be surpised to see $1.50+ with AB Labs sales license, and $2.00+ with Acreage Farm sales license.

They have also many other assets and other project development that are vey promising. They have cash in hand, strong investor base with Canaccord investors, and a tight float (85M shares including options... 27M warrants but at much higher price).

Best of Lucl

Bullboard Posts